AAAAAA
Results:
1-20
|
Results: 20
Authors:
Alkharfy, KM
Frye, RF
Citation: Km. Alkharfy et Rf. Frye, High-performance liquid chromatographic assay for acetaminophen glucuronide in human liver microsomes, J CHROMAT B, 753(2), 2001, pp. 303-308
Authors:
Hutzler, JM
Frye, RF
Korzekwa, KR
Branch, RA
Huang, SM
Tracy, TS
Citation: Jm. Hutzler et al., Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone, EUR J PH SC, 14(1), 2001, pp. 47-52
Authors:
Manley, HJ
Bailie, GR
Frye, RF
McGoldrick, MD
Citation: Hj. Manley et al., Intravenous vancomycin pharmacokinetics in automated peritoneal dialysis patients, PERIT DIA I, 21(4), 2001, pp. 378-385
Authors:
Sowinski, KM
Mueller, BA
Grabe, DW
Manley, HJ
Frye, RF
Bailie, GR
Marx, MA
Citation: Km. Sowinski et al., Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers, AM J KIDNEY, 37(4), 2001, pp. 766-776
Authors:
Dowling, TC
Frye, RF
Fraley, DS
Matzke, GR
Citation: Tc. Dowling et al., Characterization of tubular functional capacity in humans using para-aminohippurate and famotidine, KIDNEY INT, 59(1), 2001, pp. 295-303
Authors:
Hutzler, JM
Frye, RF
Tracy, TS
Citation: Jm. Hutzler et al., Sensitive and specific high-performance liquid chromatographic assay for 4'-hydroxyflurbiprofen and flurbiprofen in human urine and plasma, J CHROMAT B, 749(1), 2000, pp. 119-125
Authors:
Rosen, DA
Morris, JL
Rosen, KR
Nelson, ER
Steelman, RJ
Gustafson, RA
Wilhelm, JA
Chang, CT
Thackara, JW
Frye, RF
Citation: Da. Rosen et al., Nalmefene to prevent epidural narcotic side effects in pediatric patients:A pharmacokinetic and safely study, PHARMACOTHE, 20(7), 2000, pp. 745-749
Authors:
Matzke, GR
Frye, RF
Joy, MS
Palevsky, PM
Citation: Gr. Matzke et al., Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis, PHARMACOTHE, 20(6), 2000, pp. 635-643
Authors:
Matzke, GR
Frye, RF
Early, JJ
Straka, RJ
Carson, SW
Citation: Gr. Matzke et al., Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity, PHARMACOTHE, 20(2), 2000, pp. 182-190
Authors:
Frye, RF
Kroboth, PD
Kroboth, FJ
Stone, RA
Folan, M
Salek, FS
Pollock, BG
Linares, AM
Hakala, C
Citation: Rf. Frye et al., Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults, J CLIN PHAR, 40(6), 2000, pp. 596-605
Authors:
Matzke, GR
Frye, RF
Joy, MS
Palevsky, PM
Citation: Gr. Matzke et al., Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis, ANTIM AG CH, 44(6), 2000, pp. 1639-1644
Authors:
Alkharfy, KM
Kellum, JA
Frye, RF
Matzke, GR
Citation: Km. Alkharfy et al., Effect of ceftazidime on systemic cytokine concentrations in rats, ANTIM AG CH, 44(11), 2000, pp. 3217-3219
Authors:
Branch, RA
Adedoyin, A
Frye, RF
Wilson, JW
Romkes, M
Citation: Ra. Branch et al., In vivo modulation of CYP enzymes by quinidine and rifampin, CLIN PHARM, 68(4), 2000, pp. 401-411
Authors:
Dowling, TC
Frye, RF
Citation: Tc. Dowling et Rf. Frye, Determination of famotidine in human plasma and urine by high-performance liquid chromatography, J CHROMAT B, 732(1), 1999, pp. 239-243
Authors:
Manley, HJ
Bailie, GR
Asher, RD
Eisele, G
Frye, RF
Citation: Hj. Manley et al., Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients, PERIT DIA I, 19(1), 1999, pp. 65-70
Authors:
Dowling, TC
Frye, RF
Fraley, DS
Matzke, GR
Citation: Tc. Dowling et al., Comparison of iothalamate clearance methods for measuring GFR, PHARMACOTHE, 19(8), 1999, pp. 943-950
Authors:
Grabe, DW
Bailie, GR
Eisele, G
Frye, RF
Citation: Dw. Grabe et al., Pharmacokinetics of intermittent intraperitoneal ceftazidime, AM J KIDNEY, 33(1), 1999, pp. 111-117
Authors:
Kroboth, PD
Salek, FS
Pittenger, AL
Fabian, TJ
Frye, RF
Citation: Pd. Kroboth et al., DHEA and DHEA-S: A review, J CLIN PHAR, 39(4), 1999, pp. 327-348
Authors:
Frye, RF
Tammara, B
Cowart, TD
Bramer, SL
Citation: Rf. Frye et al., Effect of disulfiram-mediated CYP2E1 inhibition on the disposition of vesnarinone, J CLIN PHAR, 39(11), 1999, pp. 1177-1183
Authors:
Adedoyin, A
Frye, RF
Mauro, K
Branch, RA
Citation: A. Adedoyin et al., Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail (vol 46, pg 215, 1998), BR J CL PH, 46(6), 1998, pp. 616-616
Risultati:
1-20
|